Worth reading the coverage from STAT News: To view or add a comment, sign in Tirzepatide: Redefining Outcomes in Diabetes & Obesity Care Clinical trials show tirzepatide, a dual GIP/GLP-1 receptor agonist, is delivering results beyond expectations: Up to 20.9% mean weight loss at 72 weeks (SURMOUNT-1, NEJM) 94% risk reduction in progression from prediabetes to type 2 diabetes over 3 years Superior HbA1c reduction and weight control vs leading GLP-1 therapies (SURPASS program) With manageable side effects and durable outcomes, tirzepatide is reshaping how we approach metabolic disease
Research published in the Archives of Dermatological Research demonstrates that AHK-Cu at concentrations as low as 10 to the negative twelfth molar stimulates hair follicle elongation in laboratory conditions
The first step is to find a healthcare provider who specializes in this area
D'arino A, Caputo S, Bellei B
Herbal teas, like peppermint or ginger tea, can also help increase your fluid intake
Ozempic and Wegovy for Weight Loss Online
